Industry & Policy News

[Medigene AG] Medigene AG reported final Phase I dose escalation results from first-in-human Study of HLA-A*02:01-restricted PRAME-specific T cell receptor engineered T cell (TCR-T) therapy for high-risk myeloid and lymphoid neoplasms.

[Cornell University] Joeva Barrow, assistant professor of molecular nutrition in the Division of Nutritional Sciences in the College of Human Ecology, won a 2022 Hartwell Individual Biomedical Research Award, which funds scientists pursuing early stage, cutting-edge biomedical research to advance children’s health.

[Case Western Reserve University] Researchers from Case Western Reserve University (CWRU) and University Hospitals Cleveland Medical Center (UH) have secured $6.2 million from two grants awarded in the same month from the National Institutes of Health (NIH) to predict cardiovascular disease through new artificial intelligence approaches.

[Nature] Long-awaited decision comes more than a year after Francis Collins resigned as director of the largest public funder of biomedical research in the world.

[Nature News & Views] More than 40 editors have resigned from two leading neuroscience journals in protest against what the editors say are excessively high article-processing charges set by the publisher. They say that the fees, which publishers use to cover publishing services and in some cases make money, are unethical.

[Fierce Biotech] The Metrodora Institute has opened the doors of its medical and research center in Salt Lake City, giving biopharma companies a new neuroimmune drug development and clinical trial partner in Utah.